NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,316 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,316 Papers indexed
1,440 Papers AI scored
40,316 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-11 10:15 AM
1 Sensitive LC-MS/MS Method for Simultaneous Quantification of Alectinib and Its Major Metabolite M4 in Limited-Volume Human Plasma. Biomedical chromatography : BMC — Nov 11, 2026 2 Patient reimbursement in therapeutic cancer clinical trials: An 18-year multicenter experience. Cancer — Nov 11, 2026 3 Adulthood risk of non-communicable diseases associated with childhood and adolescent malnutrition in low- and middle-income countries: a systematic review of observational studies. BMJ global health — Nov 11, 2026 4 Parental night shift work and risk of breast cancer in daughters. Environmental research — Nov 11, 2026 5 Influence of diaphragm structure and function on the exercise ventilatory response in childhood cancer survivors and non-cancer controls. Respiratory medicine — Nov 11, 2026 6 Pregnancy and classic Hodgkin lymphoma: real world outcomes from a single center in Egypt. Current problems in cancer — Nov 11, 2026 7 Racial and Ethnic Differences in the Incidence of Langerhans Cell Histiocytosis Across the Age Spectrum. Blood advances — Nov 11, 2026 8 International Cross-Age Consensus Guideline on Measurable Residual Disease Assessment in Acute Lymphoblastic Leukemia. Blood — Nov 11, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40316 results
D
Lung Adenocarcinoma and Genetic Cancer Predisposition in an Adolescent.
PMID 42012024 Published: 2026-04-21 Ingested: 2026-08-02 12:06 AM Pediatric blood & cancer
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Comments on "Hydrocephalus in pediatric posterior fossa tumors: predictors and outcomes from a single center in Latin America".
PMID 41995879 Published: 2026-04-17 Ingested: 2026-08-02 12:06 AM Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Severe Hypercalcemia and Acute Kidney Injury as Initial Manifestations of Multisystem Sarcoidosis in an Adolescent With Type 1 Diabetes: A Case Report.
PMID 41994740 Published: 2026-03-12 Ingested: 2026-08-02 12:06 AM Cureus
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
INST'AJA: a co-designed Instagram campaign to promote sexual health education and behaviors in adolescent and young adult cancer survivors.
PMID 41990122 Published: 2026-04-09 Ingested: 2026-08-02 12:06 AM The journal of sexual medicine
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Thirteen Foreign Bodies Retained in the Vagina for More Than 20 Years in a Postmenopausal Woman: Case Report.
PMID 41982792 Published: 2026-04-09 Ingested: 2026-08-02 12:06 AM International journal of women's health
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Turning Expert Consensus Into Evidence: European Standards of Clinical Practice for Very Rare Pediatric Tumors in the Era of Big Data, Artificial Intelligence, and Patient Partnership.
PMID 41964307 Published: 2026-04-11 Ingested: 2026-08-02 12:06 AM Pediatric blood & cancer
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
EWSR1 Rearrangement in Pediatric B-Lymphoblastic Lymphoma: A Diagnostic Pitfall.
PMID 41963723 Published: 2026-04-11 Ingested: 2026-08-02 12:06 AM Indian journal of pediatrics
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Protecting Children This World Health Day: The Case for Early Childhood Cancer Detection Through Primary Health Care Strengthening in Vietnam.
PMID 41960832 Published: 2026-04-10 Ingested: 2026-08-02 12:06 AM Pediatric blood & cancer
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Enterococcal bacteremia in children with malignancy or after hematopoietic stem cell transplantation: real-world multicenter data from a nationwide survey in Poland (2014-2021).
PMID 41951945 Published: 2026-04-08 Ingested: 2026-08-02 12:06 AM European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Inflammatory myofibroblastic tumor of omentum mimicking an ovarian lesion: A case report.
PMID 41937800 Published: 2026-03-23 Ingested: 2026-08-02 12:06 AM Radiology case reports
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Less than Half of Pediatric Cancer Survivors have Protective Titres of Anti-HBs Antibodies.
PMID 41936737 Published: 2026-04-06 Ingested: 2026-08-02 12:06 AM Indian journal of pediatrics
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

Previous
Page 3047 of 3360
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic